One vs Three HIPEC Cycles After CRS for Pseudomyxoma Peritonei — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

One vs Three HIPEC Cycles After CRS for Pseudomyxoma Peritonei — Stella

Home/Pseudomyxoma Peritonei/

View on ClinicalTrials.gov

Recruiting

Back to Pseudomyxoma Peritonei trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

Tsinghua University affiliated Beijing Tsinghua Changgung Hospital, Beijing, Changping

Key details

Sponsor

Beijing Tsinghua Chang Gung Hospital

Enrollment target

~132 participants

Started

November 2025

Primary completion

November 2028

Age range

18 Years – 70 Years

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.